Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides

Antiphospholipid syndrome (APS) is characterized by recurrent fetal loss, repeated thromboembolic phenomena, and thrombocytopenia. The syndrome is believed to be caused by antiphospholipid beta-2-glycoprotein-I (β2GPI)-dependent Abs or anti-β2GPI Abs by themselves. Using a hexapeptide phage display...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	Blank, Miri, Shoenfeld, Yehuda, Cabilly, Shmuel, Heldman, Yehudit, Fridkin, Mati, Katchalski-Katzir, Ephraim
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 1999
Assuntos:	Biological Sciences
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC21834/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10220436/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.96.9.5164
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!